This message was sent to ##Email##
|
|
|
|
|
| |
| ACS CANCER PROGRAMS UPDATES |
ACS
The American College of Surgeons (ACS) has issued a call for abstracts to be presented at our 2019 Quality and Safety Conference, July 19-22, at the Walter E. Convention Center in Washington, D.C. The deadline for submitting abstracts is Feb. 1, 2019.
Individuals at participating sites are encouraged to submit a 250-word abstract for poster and/or podium presentation. The abstract should relate to surgical quality improvement initiatives including the development, implementation or validation of best practices within one or more of the following ACS Quality Programs:
- ACS National Surgical Quality Improvement Program (ACS NSQIP®)
- ACS Children’s Surgery Verification and ACS NSQIP Pediatric
- Cancer Programs, including the Commission on Cancer (CoC) and National Accreditation Program for Breast Centers (NAPBC)
- Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP)
- Trauma Quality Programs, including Pediatrics, Verification, Trauma Quality Improvement Program (TQIP), and Performance Improvement and Patient Safety
Upcoming deadlines
Abstract submissions close Feb. 1, 2019
Acceptance notices sent May 1, 2019
READ MORE
|
Promoted by
|
|
|
|
 |
ACS
The Commission on Cancer (CoC) invites all practicing physicians at CoC-accredited programs to submit an application to join the CoC Surveyor Team. If you are passionate about the CoC and its Standards, we are looking for you! Consider becoming part of the CoC Surveyor team and share your commitment for providing patients with high-quality, patient-centered, multidisciplinary care.
In order to meet the ever-increasing number of programs interested in CoC accreditation, we need your support and expertise. Click here to access the application.
If you have questions please contact accreditation@facs.org.
ACS
At Clinical Congress 2018, the inaugural SurgeonsVoice Advocate of the Year award was presented to Alan G. Thorson, MD, FACS, a colon and rectal surgeon in Omaha, Nebraska, for his commitment to the American College of Surgeons (ACS) advocacy and political efforts, particularly through his involvement with the Commission on Cancer. Thorson will also be featured in the Bulletin of the American College of Surgeons.
READ MORE
 |
|
Our ihcDirect® method yields a revolutionary technology that opens a spectrum of new clinical applications including intraoperative surgery. Using the Novodiax PolyHRP technology, Intraoperative IHC tests can now be completed in just 10 minutes using fresh frozen tissues.
For more details, see our
 ihcDirect® product list.
|
|
ACS
The CAnswer Forum is an interactive virtual Bulletin Board for Commission on Cancer constituents to ask questions, search topics, and connect with the latest CoC activities. It continues to serve as an open forum for networking and discussion of multiple topics including the National Cancer Database (NCDB), Facility Oncology Registry Data Standards (FORDS), and STandards for Oncology Registry Entry (STORE). The NCDB encourages CoC-accredited programs to utilize the CAnswer Forum to share best practices, submit questions regarding unusual scenarios and seek guidance in understanding coding instructions. For program-specific questions, please contact ncdb@facs.org, include the program FIN and specifics of the issues to allow the NCDB staff to respond appropriately.
READ MORE
AJCC
The AJCC Cancer Staging Manual, Eighth Edition is the first edition to have an electronic book (eBook) version. It is available for purchase now on Amazon and is the most current version of the manual (September 2018).
Since 1977, the American Joint Committee on Cancer (AJCC) has published eight editions of cancer staging manuals using contemporary, evidenced-based literature to build a common language of cancer for the care of cancer patients by clinicians and for the cancer surveillance community. The print version of the eighth edition was first published in October 2016 and went into effect for all cancer cases diagnosed on or after Jan. 1, 2018. The eighth edition presents evidence-based revisions for the staging of cancer for a number of organ sites. The chapters include the rationale and rules for staging; the definitions of tumor, lymph node involvement and metastasis; stage groupings; and histologic grade.
There have been updates since the first printing of the eighth edition, all of which are incorporated in this eBook version available through Amazon’s Kindle. The Kindle version can be used on any device (PC, MAC, iPhone, iPad, Android) with the free Kindle app. The electronic version allows for highlighting, adding notes and bookmarks and creating flashcards. The AJCC has a curated FAQ document to address common questions that can be accessed at cancerstaging.org. All other questions related to the eighth edition can be sent to ajcc@facs.org.
READ MORE
|
Promoted by
|
|
|
|
 |
ACS
April 7–9, 2019 – Rosemont (Chicago), Illinois
The 2019 Cancer Programs Cluster Workshops will be three individual one-day workshops on consecutive days, in one location, for your convenience. You may attend just one workshop or all three. Sign up here for further information as it becomes available.
NCCRT
The 2017 national average for CRC screening in HRSA-funded health centers was released last month and is at 42 percent, which increased from 39.9 percent in 2015, meaning an additional 223,100 patients were screened in the last year alone and an additional 467,500 patients were screened in the last 2 years. That’s almost half a million people! Visit the HRSA website for an additional understanding of the rates. View our 80 percent by 2018 Hall of Fame to see the list of these centers that are meeting or exceeding our shared goal. (And if you or a partner you know of is exceeding 80 percent, you can submit them to the Hall of Fame!) Thanks to Laura Makaroff for sharing the data. Most importantly, congratulations to all our colleagues working in health centers, as well as to the many of you who work to support health centers on this continued improvement!
READ MORE
|
|
|
|
|
| |
Clinical Research Program
As mentioned in prior communications, the 2018 DCIS Special Study opened July 16. We invite you to visit the 2018 Special Study on DCIS SharePoint site, which will house all materials you will need to participate in the study. We have created a universal login for this site; please note it is case sensitive:
Login: DCISStudy
Password: study2018.
All registrars and co-registrars will be able to access and download materials via the SharePoint site.
READ MORE
| HEALTH CARE NEWS AND UPDATES |
Medical News Today
Researchers at the University of Gothenburg in Sweden have added new data to a study of the effects of antioxidants on malignant tumor development.
In earlier work with human cancer tissue and mouse models, the researchers demonstrated that antioxidants could hasten the development of lung cancer and accelerate the spread of malignant melanoma, an uncommon but invasive form of skin cancer.
READ MORE
 |
|
Clinical Cancer Coding is hard. HLA-Global’s Horizon uses advanced AI and Machine Learning to make the hard easy. Horizon has an average accuracy of 97%+ all of the time, works 24X7, costs 50% less than manual coders and continually learns. And it handles the new 2018 standards. For further information visit www.hla-global.com.
|
|
Drug Target Review
Liver cancer claims the lives of over 700,000 each year and is the second leading cause of cancer-related deaths worldwide. Due the nature of the cancer, it is usually detected too late to be cured.
Results of a new study show a huge increase in the expression of sugar-burning ‘glycolytic’ enzymes in precancerous cirrhotic livers. This increase has been associated with a significantly higher risk of developing hepatocellular carcinoma (HCC), a main type of liver cancer, and could be used as a biomarker to identify those at risk of malignancy.
READ MORE
Medical News Today
Cancer is a chronic disease that kills millions of people worldwide.
According to the World Health Organization (WHO), cancer is the second leading cause of death globally and is likely to be responsible for more than 9 million deaths in 2018.
Globally, medical professionals will diagnose cancer in around 18 million people in 2018, and the number of new cases per year will reach more than 23 million by 2030.
READ MORE
Medical Xpress
The selection of a first-line chemotherapy drug to treat many types of cancer is often a clear-cut decision governed by standard-of-care protocols, but what drug should be used next if the first one fails? That's where Georgia Institute of Technology researchers believe their new open source decision support tool could come in. Using machine learning to analyze RNA expression tied to information about patient outcomes with specific drugs, the open source tool could help clinicians chose the chemotherapy drug most likely to attack the disease in individual patients.
READ MORE
University at Buffalo
The tool — described in a pair of research papers published in IEEE Journal of Selected Topics in Quantum Electronics and ACS Sensors — is based upon a unique gold biosensor the research team created. When paired with a computer or smartphone and other inexpensive tools, the system is capable of spotting cancer biomarkers from a blood sample.
READ MORE
EurekaAlert
Melbourne scientists have discovered how tumor development is driven by mutations in the most important gene in preventing cancer, p53.
The research revealed that in the early stages of cancer, mutant p53 'tackles' the normal p53 protein and blocks it from carrying out its protective role. As a result, p53 can no longer activate natural defences against cancer — such as the body's DNA repair process — increasing the risk of cancer developing.
READ MORE
| IMPORTANT DATES AND DEADLINES |
|
|
|
|
The Brief
Connect with AJCC
Connect with CoC
Connect with NAPBC
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news
Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Cancer Programs do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the authors and not of the American College of Surgeons, and the Cancer Programs.
American College of Surgeons
633 N Saint Clair Street | Chicago, IL, 60611-3211 | 800-621-4111 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox. |
|
| |
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
features posts on the industry, careers and more:
